Cargando…

Lin28 Enhances Tumorigenesis and is Associated With Advanced Human Malignancies

Multiple members of the let-7 family of miRNAs are often repressed in human cancers1,2, thereby promoting oncogenesis by de-repressing the targets K-Ras, c-Myc, and HMGA2 3,4. However, the mechanism by which let-7 miRNAs are coordinately repressed is unclear. The RNA-binding proteins Lin28 and Lin28...

Descripción completa

Detalles Bibliográficos
Autores principales: Viswanathan, Srinivas R., Powers, John T., Einhorn, William, Hoshida, Yujin, Ng, Tony, Toffanin, Sara, O'Sullivan, Maureen, Lu, Jun, Philips, Letha A., Lockhart, Victoria L., Shah, Samar P., Tanwar, Pradeep S., Mermel, Craig H., Beroukhim, Rameen, Azam, Mohammad, Teixeira, Jose, Meyerson, Matthew, Hughes, Timothy P., Llovet, Josep M, Radich, Jerald, Mullighan, Charles G., Golub, Todd R., Sorensen, Poul H., Daley, George Q.
Formato: Texto
Lenguaje:English
Publicado: 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757943/
https://www.ncbi.nlm.nih.gov/pubmed/19483683
http://dx.doi.org/10.1038/ng.392
Descripción
Sumario:Multiple members of the let-7 family of miRNAs are often repressed in human cancers1,2, thereby promoting oncogenesis by de-repressing the targets K-Ras, c-Myc, and HMGA2 3,4. However, the mechanism by which let-7 miRNAs are coordinately repressed is unclear. The RNA-binding proteins Lin28 and Lin28B block let-7 precursors from being processed to mature miRNAs5–8, suggesting that over-expression of Lin28/Lin28B might promote malignancy via repression of let-7. Here we show that LIN28 and LIN28B are over-expressed in primary human tumors and human cancer cell lines (overall frequency ∼15%), and that over-expression is linked to repression of let-7 family miRNAs and de-repression of let-7 targets. Lin28/Lin28B facilitate cellular transformation in vitro, and over-expression is associated with advanced disease across multiple tumor types. Our work provides a mechanism for the coordinate repression of let-7 miRNAs observed in a subset of human cancers, and associates activation of LIN28/LIN28B with poor clinical prognosis.